Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
-
LG EXPANDS FREE GAMING ECOSYSTEM, BRINGING HIT 8 BALL POOL TO TV SCREENS FOR THE FIRST TIME
-
Freeport Provides Third-Quarter 2026 Operational Update
-
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
-
Teknisa Joins Volaris Group
-
Tranquil Healthcare Fund I, LLC Announces up to $50 Million Regulation A Offering Available to Investors
-
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases
-
InTest Corporation to Participate in 18th Annual CEO Investor Summit on October 13
-
Tenet to Report Its Third Quarter 2026 Results on October 29
-
R. Jude Samulski Receives Inaugural Founders Award from Chinese Society of Gene & Cell Therapy
-
Global Industrial 2026 National Trade Show Showcases Industrial-Strength Solutions That Keep Customer Operations Running Strong
-
SGS acquires Prescient Security in the US, an expert in enterprise cybersecurity and digital compliance
-
GridCARE Power Acceleration™ to Help California Utility Support Faster Customer Energization
-
Supernal’s AI-Assisted ‘The Thorne Protocol’ Takes Third Place in Global Future Vision XPRIZE and SPECS Audience Choice Award
-
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial Facility Dedicated to the Production of Lead-212-Based Targeted Alpha Therapies
-
Bally’s Corporation Closes Previously Announced Financing to Support the Development of the Bally’s Bronx Project
-
New Preliminary Real-World VEOZAH™ (fezolinetant) Data Highlights Improvements in Menopause-Related Symptoms and Sleep Outcomes
-
SimpleClosure and Intuit QuickBooks Partner to Help Businesses Stay Compliant When Closing Payroll Tax Accounts
-
Vontier Brings the Connected Retail Ecosystem to Life at NACS 2026
-
EMD Electronics Opens New R&D Facility in Wisconsin to Accelerate Advanced Semiconductor Materials Innovation
-
Hayward Holdings Names New Chief Accounting Officer
-
BlueWind Medical Announces Category I CPT Code for Subfascial Tibial Neuromodulation
-
Sole Source Capital Appoints Claire Bissot as Chief Human Resources Officer
-
Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System
-
Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics
-
Blade’s BLADEone Enhanced Jet Service Returns with Flights between the New York City area and South Florida, in Partnership with Aero
-
BODi Expands P90X Performance Portfolio with P90X Energy Drinks
-
Revvity to Hold Earnings Call on November 3, 2026
-
Talkiatry Expands Therapy Nationwide, Now Available Alongside Psychiatric Care in All 50 States
-
Druva Announces 2026 North Star Award Winners
-
Crypto News: Remittix Opens PayFi Testing to 1,000 Users as Bitcoin Price Prediction Eyes $100,000 and Litecoin Hits Eight-Month High
-
Arowana recertifies as a Certified B Corporation under B Lab's new global standards
-
Applied Digital Brings an Additional 75 MW of AI Infrastructure Online at Polaris Forge 1
-
Satellogic Announces Successful Launch of First Merlin Satellite
-
EMD Electronics Opens New R&D Facility in Wisconsin to Accelerate Advanced Semiconductor Materials Innovation
-
Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026
-
Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
-
NETSOL Technologies appoints Michael Ramsey as Vice President of Sales for Asset Finance in the Americas
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization
-
SUTNTIB AB Tewox publishes its NAV for September 2026
-
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
-
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
-
Duke Robotics Appoints Capital Markets and Public Company Finance Veteran Avi Levin as Chief Financial Officer
-
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CME Group Reports Record Average Daily Volume for September and Q3, Driven by Growth Across Asset Classes
-
AL MOUJ MUSCAT ADVANCES BUSINESS GROWTH AS FULLY SOLD BUSINESS PARK MOVES TOWARDS OCCUPANCY
-
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
-
HireQuotient’s EasySource Elevated to Featured Listing on Paylocity Marketplace Within a Month of Launching
-
Corbin Advisors Named 2026 Connecticut Business Excellence Award Winner by Hartford Business Journal
